Achieve Life Sciences
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Achieve Life Sciences
Evolving challenges will keep the COVID-19 pipeline active, while oncology, immunology and CNS are areas also expected to see much progress in 2022. Industry executives look forward to the year in therapeutic R&D.
Around 100 executives highlight the hot areas to watch on the R&D front in 2021. From cancer to CNS and from regenerative medicine to real world data, expectations are high on many fronts.